Call Options Transactions Made in Q2 2023 in Neurocrine Biosciences Inc (NBIX)
This table provides information about the institutional ownership of Neurocrine Biosciences Inc (NBIX) during Q2 2023. The information is specifically focused on institutions that hold call options of NEUROCRINE BIOSCIENCES INC.
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Aug 11, 2023
Q2 2023
|
Susquehanna International Group, LLP
Bala Cynwyd, PA |
BUY
|
CALL |
95.3K+ 196.49% |
$8.53M - $9.99M
|
144K
$17.1M
|
|
|
Aug 14, 2023
Q2 2023
|
Balyasny Asset Management LLC
Chicago, IL |
BUY
|
CALL |
50KNew |
$4.48M - $5.24M
|
50K
$5.96M
|
|
|
Aug 14, 2023
Q2 2023
|
J. Goldman & CO LP
New York, NY |
BUY
|
CALL |
39.4KNew |
$3.53M - $4.13M
|
39.4K
$4.69M
|
|
|
Aug 10, 2023
Q2 2023
|
Citigroup Inc
|
BUY
|
CALL |
30K+ 100.0% |
$2.69M - $3.15M
|
60K
$7.15M
|
|
|
Aug 14, 2023
Q2 2023
|
Caption Management, LLC
Oklahoma City, OK |
BUY
|
CALL |
15K+ 50.0% |
$1.34M - $1.57M
|
45K
$5.36M
|
|
|
Aug 14, 2023
Q2 2023
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
BUY
|
CALL |
3.1K+ 12.45% |
$278K - $325K
|
28K
$3.34M
|